The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Unexplained itching with no visible rash is more common than you think. Learn how your brain and nerves play a role in the ...

Perioral dermatitis is a skin condition characterized by a rash around the mouth ... “Patients often complain of itching and burning,” she says. “Since certain topicals can exacerbate ...

The Trump administration appears to be fast-tracking an Australian company’s lithium project in southeastern Oregon. The U.S. Bureau of Land Management on Wednesday published its environmental ...

April 3 (Reuters) - Australia's Galan Lithium (GLN.AX), opens new tab said on Thursday that it rejected an offer from Zhejiang Huayou Cobalt Co (603799.SS), opens new tab and Renault Group (RENA ...

Itching is the most common symptom of an allergic ... The itchiness may be in your mouth or on your skin, often in the form of a rash such as hives or eczema. You might also have swelling.

The affected area may be discolored, inflamed, and have pus-filled blisters. In some cases, a rash is itchy and accompanied by other symptoms, such as a fever. Figuring out a rash's cause is key to ...

April 1 (Reuters) - Lithium Americas (LAC.TO), opens new tab said on Tuesday it has reached a final investment decision (FID) for constructing the first phase of the Thacker Pass lithium mine in ...

A new recycling method from researchers in China offers the most eco-friendly solution yet to the waste from lithium-ion batteries, the Independent reported. Lithium-ion batteries are currently the ...

Adding more uncertainty to the already delicate ecosystem, the multi-billion-dollar lithium find has set off a race between the public and private sectors to extract the valuable resource from the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...